Media Coverage
The work done by Northwestern University Feinberg School of Medicine faculty members (and even some students) is regularly highlighted in newspapers, online media outlets and more. Below you’ll find links to articles and videos of Feinberg in the news.
-
CBS News Chicago
–
Northwestern Medicine team researching brain tumors benefits from nonprofit’s funding
A Northwestern Medicine research team is constantly searching for tumor treatments and funding is a factor. “You just need somebody to give you a chance,” said Craig Horbinski, MD, PhD, a Northwestern medicine neuropathologists and professor of pathology at Northwestern University Feinberg School of Medicine. Horbinski said the results of work paid for by hisfirst grant led to more funding. Now, scientists under his watch are studying how to shrink tumors, especially fast-growing and deadly glioblastomas. About 800 kids and adults are diagnosed with brain tumors every day. The hope is to continue funding research, so every patient can bounce back.
-
Yahoo! News
–
Men have Viagra. What do women have for low libido? Here’s what experts say.
For erectile dysfunction, men have plenty of drugs to choose from, including Cialis, Levitra, Stendra and Viagra, otherwise known as the “little blue pill.” For women, the treatment options are less robust. While medications designed for men focus on increasing blood flow to the penis, allowing for an erection and sexual function, most women are physically capable of engaging in intercourse without the help of medication. That said, there are drugs available that purport to get women in the mood for sex. That includes flibanserin, the trade name for which is Addyi. Thus far, the drug has been approved by the Food and Drug Administration only for premenopausal women. “When they first came out, they were putting themselves out there as the female Viagra — the ‘little pink pill’ instead of the ‘little blue pill.’ That really is misleading, because it was always about libido,” says Dr. Lauren Streicher, professor of obstetrics and gynecology at Northwestern University.
-
WebMD
–
New AI-Enhanced Bandages Poised to Transform Wound Treatment
You cut yourself. You put on a bandage. In a week or so, your wound heals. Most people take this for granted. But for the more than 8.2 million Americans who have chronic wounds, it’s not so simple. Traumatic injuries, post-surgical complications, advanced age, and chronic illnesses like diabetes and vascular disease can all disrupt the delicate healing process, leading to wounds that last months or years. smart bandage, developed at Northwestern University, harmlessly dissolves — electrodes and all — into the body after it is no longer needed, eliminating what can be a painful removal. Guillermo Ameer, ScD, a study author reporting on the technology in Science Advances and professor of surgery (vascular surgery) at Northwestern University Feinberg School of Medicine, hopes it could be made cheaply and used in developing countries. “We’d like to create something that you could use in your home, even in a very remote village,” said Ameer.
-
US News & World Report
–
AI Equals Human Radiologists at Interpreting Breast Cancer Scans
Another study is showing that artificial intelligence (AI) is as good as a specialist doctor in spotting breast cancer on a mammogram. But don’t expect computers to take over the job from humans, experts say. On average, both humans and AI caught about 90% of breast tumors, and correctly gave an all-clear to just over three-quarters of mammograms from women without cancer. No one, however, is saying that AI should replace radiologists in mammography-reading. Instead, it might help them do the job more efficiently and accurately, said Mozziyar Etemadi, MD, PhD, an assistant professor of anesthesiology at Northwestern University Feinberg School of Medicine in Chicago. Etemadi, who is not a radiologist, studies AI’s potential role in medicine. The simple fact, he said, is that “humans have a certain level of missing stuff,” and AI could help. It might, for example, give mammograms a first pass, flagging ones that look suspicious so radiologists can prioritize them, he said. And in any given mammogram, AI might highlight areas that seem abnormal.
-
The Washington Post
–
For students with food allergies, college campuses can be hazardous
Living with a food allergy at home is challenging under the best of circumstances. But college students say navigating food allergies on campus is particularly fraught. Nearly a dozen current and recent college students with food allergies shared stories of encountering allergens in campus dining halls, during dorm-life shenanigans and at off-campus events. “They’re all growing up and taking their food allergies into college,” said Ruchi Gupta, MD, MPH, a physician and the founding director of the Center for Food Allergy and Asthma Research (CFAAR) at Northwestern Medicine. “We’re talking about 10 percent of a college population learning how to be independent for the first time, making food choices on their own, and that coinciding with wanting to be accepted, make friends, eat out and go to parties.” The true scope of the problem is unknown, Gupta said, partly because college students are not required to declare their food allergies on applications. It is even harder to quantify how many of them experience anaphylaxis — a life-threatening allergic reaction — while on campus.
-
Fox 32 Chicago
–
Northwestern Medicine launches cultural program for Spanish-speaking lung and thoracic disease patients
Northwestern Medicine is launching a new cultural program for patients with lung and thoracic diseases. Doctors say the program focuses on patients who prefer to communicate in Spanish and offers culturally competent medical care. “The language barrier is a significant limitation for patients with respiratory disease and thoracic disease to seek health care and to complete the treatments that are recommended. So what we think, what we want to provide with this program, is to take the language barrier out of the equation,” said Dr. Diego Avella Patino, Northwestern Medicine Hispanic Program at Canning Thoracic Institute. Every team member working with the program speaks Spanish, and they have a dedicated phone line for patients who prefer to communicate in Spanish.
-
WebMD
–
Who Gets Wegovy? (Hint: Not Always Those Who Need it Most)
Semaglutide is better known as the active ingredient in a number of brand-name drugs (Ozempic, Rybelsus, and Wegovy). Sometimes called GLP-1 agonists, doctors use these medications at different doses to treat various health conditions, including obesity and type 2 diabetes. Research shows people with overweight or obesity can lower their weight by 12% to 15% with certain doses of semaglutide. The drug acts on brain signals, which seems to be why many people feel full faster and with less food while they take it. However, many government-sponsored plans like Medicare don’t cover weight loss drugs at all when used for obesity alone. This lack of access can be frustrating for everyone, but may take a greater toll on certain historically marginalized groups and people of color – people like Martinez, who is Hispanic of Puerto Rican descent. There are a number of reasons for this, says Veronica Johnson, MD, an obesity medicine specialist at Northwestern Medicine and assistant professor of general internal medicine at Northwestern University Feinberg School of Medicine. (Johnson has consulted with Novo Nordisk, the U.S. producer of semaglutide.)
-
WBEZ Chicago
–
Northwestern doctors say long COVID detected even after patients tested negative
Ibrahim is among an estimated 1 in 13 adults in the United States who suffered from long-term COVID-19 effects and symptoms, which also included brain fog, migraines and fatigue. Ibrahim is one of potentially millions of people across the U.S. who showed so-called long-COVID symptoms as far back as 2020 even though she initially tested negative for the virus back then, Northwestern University researchers say in a new study. Researchers found people who complained of symptoms consistent with long COVID but were not formally diagnosed during their infection. The Northwestern Medicine Neuro COVID-19 Clinic did not deny appointments to those who had long-COVID symptoms, says Dr. Igor Koralnik, who oversees the clinic and led the research. The study included 29 patients, mostly females. Women appear to be affected by autoimmune diseases and responses more often than men, leading to symptoms consistent with long-COVID effects, Koralnik said.
-
Chicago Tribune
–
Can AC protect against wildfire smoke? How Chicagoans can stay safe from bad air while indoors.
As climate change increases the severity and frequency of wildfires in North America, experts say many Americans are at risk of experiencing one in their lifetime. But even more may be affected by the unhealthy air quality from the smoke the fires produce. To complicate matters further, experts say staying indoors with the windows closed is only the first step. Chicagoans should purchase an air purifier with HEPA filters, said Ravi Kalhan, MD, a pulmonologist at Northwestern Medicine. “You could think of these filters like putting a giant N95 mask on your room, and having all the air pass through it,” Kalhan said. Other kinds of air purifiers — such as those that rely on ultraviolet light or ionizers — won’t help with pollution caused by wildfire smoke, Kalhan said. And air purifiers with ionizers can be dangerous for people with lung conditions, he said.
-
Chicago Tribune
–
Chicago COVID-19 cases and hospitalizations on the rise; Northwestern team warns of undiagnosed long-COVID consequences
Chicago’s COVID-19 cases and hospitalizations are continuing to steadily rise after reaching pandemic lows earlier this summer. City health officials say the rise doesn’t present an urgent threat to the public, but shows the coronavirus is still spreading and merits attention. new study released Wednesday by the center suggests millions of people who never tested positive for COVID-19 may have such lingering symptoms. Because they don’t have a positive test to prove they got sick, they might miss out on care, the center’s co-director Igor Koralnik, MD, professor of neurology (neuro-infectious disease and global neurology) at Northwestern University Feinberg School of Medicine said. “There is a large population in the U.S. and world who are the negative long-haulers. Those patients have been rejected and stigmatized because they have all the symptoms, but they don’t have a positive COVID test,” Koralnik said. Most post-COVID clinics don’t accept people who haven’t gotten positive tests, Koralnik said. Research on long COVID often excludes them too, he said.
